Position in TNYA
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$6,094,795
-$2,110,272 QoQ
Shares Held
8,560,108
+69.0% QoQ
Ownership
3.94%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 8.13183665439735.ToString("F0")%
None 91.86816334560265.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. TNYA ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in TNYA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6,094,795 | 8,560,108 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $8,205,067 | 5,064,857 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,905,504 | 4,755,327 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,326,757 | 4,082,032 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,679,021 | 3,272,044 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,201,411 | 3,213,167 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,809,223 | 3,164,266 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,973,050 | 2,862,916 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,968,597 | 2,459,444 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $5,528,062 | 2,167,868 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $11,736,354 | 1,999,379 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,322,735 | 1,867,627 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $3,248,592 | 1,616,216 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,075,637 | 1,060,565 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,987,706 | 1,063,536 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,789,108 | 1,085,663 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,551,700 | 556,818 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,386,702 | 502,988 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||